Innosys Past Earnings Performance
Past criteria checks 2/6
Innosys has been growing earnings at an average annual rate of 15.7%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 3.8% per year. Innosys's return on equity is 2.4%, and it has net margins of 5.5%.
Key information
15.7%
Earnings growth rate
18.3%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 3.8% |
| Return on equity | 2.4% |
| Net Margin | 5.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Innosys makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 35,890 | 1,976 | 9,000 | 4,462 |
| 31 Mar 24 | 35,276 | 1,398 | 9,994 | 4,462 |
| 31 Dec 23 | 34,969 | 1,629 | 10,034 | 4,462 |
| 30 Sep 23 | 33,362 | 101,946 | 25,112 | 2,072 |
| 30 Jun 23 | 35,607 | -19,518 | 27,182 | 2,168 |
| 31 Mar 23 | 40,546 | -18,606 | 25,040 | 3,351 |
| 31 Dec 22 | 41,169 | -18,540 | 23,366 | 4,471 |
| 30 Sep 22 | 43,001 | -122,338 | 12,053 | 4,608 |
| 30 Jun 22 | 40,778 | -4,506 | 11,042 | 4,669 |
| 31 Mar 22 | 38,327 | -5,473 | 10,801 | 4,995 |
| 31 Dec 21 | 38,055 | -4,970 | 10,417 | 4,893 |
| 30 Sep 21 | 34,261 | -6,716 | 10,815 | 4,927 |
| 30 Jun 21 | 32,083 | -8,593 | 10,954 | 4,591 |
| 31 Mar 21 | 29,470 | -12,230 | 11,280 | 4,387 |
| 31 Dec 20 | 27,775 | -12,283 | 11,475 | 4,462 |
| 30 Sep 20 | 31,497 | -8,062 | 11,099 | 4,735 |
| 30 Jun 20 | 32,334 | -6,239 | 10,569 | 4,704 |
| 31 Mar 20 | 33,156 | -2,150 | 9,761 | 4,459 |
| 31 Dec 19 | 34,814 | -1,890 | 9,442 | 4,329 |
| 30 Sep 19 | 31,831 | -11,372 | 9,498 | 4,080 |
| 30 Jun 19 | 31,966 | -13,810 | 9,700 | 4,184 |
| 31 Mar 19 | 32,092 | -14,776 | 9,835 | 3,968 |
| 31 Dec 18 | 31,686 | -14,719 | 9,508 | 3,877 |
| 30 Sep 18 | 27,160 | -6,830 | 7,982 | 3,719 |
| 30 Jun 18 | 23,172 | -5,697 | 7,051 | 3,622 |
| 31 Mar 18 | 18,209 | -5,583 | 6,340 | 3,535 |
| 31 Dec 17 | 13,294 | -6,545 | 5,421 | 3,253 |
| 30 Sep 17 | 12,400 | -4,988 | 6,171 | 3,637 |
| 30 Jun 17 | 12,880 | -3,263 | 6,329 | 3,332 |
| 31 Mar 17 | 11,832 | -3,224 | 6,026 | 3,026 |
| 31 Dec 16 | 11,688 | -2,076 | 5,721 | 3,117 |
| 30 Sep 16 | 13,393 | -680 | 5,889 | 3,213 |
| 30 Jun 16 | 11,967 | -1,484 | 6,036 | 3,224 |
| 31 Dec 15 | 14,596 | -811 | 6,691 | 2,814 |
Quality Earnings: A056090 has a large one-off loss of ₩542.4M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: A056090 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A056090 has become profitable over the past 5 years, growing earnings by 15.7% per year.
Accelerating Growth: A056090 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A056090 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.3%).
Return on Equity
High ROE: A056090's Return on Equity (2.4%) is considered low.